Skip to main content
Equibles
CHE logo

CHE · Chemed Corp

Track CHE — free

Use CHE with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CHE

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$532.89 -1.99 (-0.37%)
Market Cap
$6.99B
Shares
13.07M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$534.88 Open$530.72 Day$528.81–544.08 52W close$368.59–552.72 Avg vol 30d166K Short int461K · 3.5% float · 2.6d Short vol77% Last earningsJul 29, 2026 DataJan 2020–Aug 2026 Filing10-Q · Jul 31

Up next

Next earnings call
Oct 31, 2026 Est · unconfirmed · in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Jul 31, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Strong Quant / Vol Moderate
      Market backdrop VIX 14.9 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +21%
      above
      Price vs 50-day avg +8%
      above
      RSI (14) 59
      neutral
      MACD trend Negative
      52-week position 90%
      near high
      Momentum
      relative strength
      Very Strong
      1-month return +6%
      trailing
      6-month return +30%
      trailing
      YTD return +25%
      this year
      Relative strength +19%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $496 › 200d $443 — 50d above 200d
      Institutional flow Accumulating
      +8% holders QoQ · +102 funds added
      Insider flow Distributing
      Net -$2.0M over 90 days · 100% sells
      Short interest Falling
      3.53% of float · ▼ -18.5% MoM · 2.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      531 holders — mid 3-yr range
      Squeeze score 56
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth +4%
      Y/Y
      EPS growth −8%
      Y/Y
      Free cash flow $325.5M
      Buyback $139.8M
      remaining
      Balance sheet $23.0M
      net debt
      Quant / Vol
      risk profile
      Moderate
      Volatility 29%
      annualized · 1-yr
      Max drawdown −23%
      past year
      ATR 2.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Jul 28, 2026
      full year
      Adjusted EBITDA margin Non-GAAP 21.5% – 22.5%
      Roto-Rooter adjusted EBITDA margin 21.5% – 22.5%
      full-year 2026
      Earnings per diluted share, excluding non-cash expenses for stoc Non-GAAP Initiated $25.00 – $25.75
      revised guidance
      Effective corporate tax rate on adjusted earnings Non-GAAP 24.5%
      Prior guidance period ended · from the 8-K filed Oct 28, 2025
      Adjusted Diluted EPS, excluding non-cash expense for stock optio · 2025 $22.00 – $22.30

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 2 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +21% Bullish
      Price vs 50-day avg
      +8% Bullish
      RSI (14)
      59 Neutral
      MACD trend
      Negative Bearish
      52-week position
      90% Bullish
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $496 › 200d $443 — 50d above 200d
      Institutional flow Accumulating
      +8% holders QoQ · +102 funds added
      Insider flow Distributing
      Net -$2.0M over 90 days · 100% sells
      Short interest Falling
      3.53% of float · ▼ -18.5% MoM · 2.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      531 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $369 Now $535 · 90% Range high $553
      vs 200-day avg +21% vs 50-day avg +8%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted EBITDA (VITAS) non-GAAP $148.46M Three Months Ended June 30, 2026 —
      Average daily census (Continuous care) 199 Three Months Ended June 30, 2026 —
      Average daily census (Homecare) 19,249 Six Months Ended June 30, 2026 —
      Average daily census (Inpatient) 326 Three Months Ended June 30, 2026 —
      Average daily census (Total) 23,208 Six Months Ended June 30, 2026 —
      Average length of stay (days) 101.9 Six Months Ended June 30, 2026 —
      Days of revenue outstanding-excluding unapplied Medicare payments 39.7 Three Months Ended June 30, 2026 —
      Days of revenue outstanding-including unapplied Medicare payments 26.9 Three Months Ended June 30, 2026 —
      Estimated uncollectible accounts as a percent of revenues 0.7% Three Months Ended June 30, 2026 —
      Gross margin 50.4% the second quarter of 2026 —
      Gross margin, excluding Medicare Cap 23.9% the second quarter of 2026 —
      Median length of stay (days) 15 Six Months Ended June 30, 2026 —
      Medicare Cap billing limitation for provider numbers at limit $7M As of June 30, 2026 —
      Medicare provider numbers with projected Cap cushion of 10% or greater 22 As of June 30, 2026 —
      Total Admissions 38,519 Six Months Ended June 30, 2026 —
      Total Discharges 36,704 Six Months Ended June 30, 2026 —
      Net Income, excluding certain discrete items non-GAAP $52.2M first quarter of 2026 —
      Adjusted EBITDA margin (Roto-Rooter) non-GAAP 21.5% the fourth quarter of 2025 —
      Gross margin (Roto-Rooter) 49.8% the fourth quarter of 2025 —
      Gross margin, excluding Medicare Cap (VITAS) non-GAAP 27.3% the fourth quarter of 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Care Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      CHE
      Chemed Corp
      this stock
      		$6.99B +25.0% +4.1% — 3.5%
      HCA
      HCA Healthcare, Inc.
      		 $90.30B -13.0% +7.1% 14.0 2.7%
      FSNUY
      Fresenius SE & Co. KGaA
      		 $30.64B -4.8% — — 0.0%
      THC
      Tenet Healthcare Corp
      		 $21.98B +37.2% +0.9% 10.5 4.0%
      FMS
      Fresenius Medical Care AG
      		 $12.49B -1.6% +5.9% — 0.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      531
      % held
      103.7%
      Net QoQ
      +363.0K sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      467
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      461.4K
      Days to cover
      2.6d
      Change
      -104.7K sh
      View
      Short Volume
      Short vol %
      77%
      As of
      Aug 20, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      2.4K
      Value
      $1.3M
      As of
      Jul 30, 2026
      View
      Off-Exchange
      Off-exchange %
      43.2%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$2.0M
      Buyers / Sellers
      0 / 4
      Buyers Sellers
      View
      Congressional Trades Buy
      Member
      Lisa McClain
      Amount
      $1.0K–$15.0K
      Traded
      Jun 24, 2025
      View
      Financials
      Financials
      Revenue (FY)
      $2.5B
      Net income (FY)
      $265.2K
      EPS diluted
      $18.34
      View
      Buybacks
      Authorized
      $300.0M
      Remaining
      $139.8M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Jul 31, 2026
      This year
      9
      View
      Proposed Sales
      Value
      $420.0K
      Shares
      1.0K
      Filed
      May 1, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 29, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      CHE -0.4% +6.3% +30.5% +0.5% +25.0%
      SPY -2.0% +3.3% +11.2% +2.1% +11.8%
      vs SPY +1.5% +3.0% +19.3% -1.6% +13.2%

      Capital returns

      Latest dividend
      $0.70 / share · ex Aug 17, 2026
      Raised 16.7%
      Paid (TTM)
      $2.50 / share · 4 payouts
      Dividend yield (TTM, derived)
      0.47%
      Buyback program · as of Jul 31, 2026
      Authorized
      $300.00M
      Spent (derived)
      $160.20M
      Remaining
      $139.80M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 19584 CUSIP 16359R103 13F (30d) 488 filings 461 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)